U.S. FDA Requirements: Isoproterenol Hydrochloride
Pharmaceutical / Drug Definition :
Acts on beta2-adrenergic receptors, causing relaxation of bronchial smooth muscle; acts on beta1-adrenergic receptors in heart, causing positive inotropic and chronotropic effects and increasing cardiac output. Also lowers peripheral vascular resistance in skeletal muscle and inhibits antigen-induced histamine release.
FDA Label Requirements and Exceptions
Isoproterenol Hydrochloride
FDA Import Information
Isoproterenol Hydrochloride
FDA Detentions
Isoproterenol Hydrochloride (Isoproterenol Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Isoproterenol Hydrochloride (Isoproterenol Hydrochloride Suppliers)
- Processors Isoproterenol Hydrochloride
- Repackers Isoproterenol Hydrochloride
- Relabelers Isoproterenol Hydrochloride
- Exporters Isoproterenol Hydrochloride
- Importers Isoproterenol Hydrochloride
For more information about Isoproterenol Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
